CVR number 10974577
Industry 86.9040 Other human health activities

KIROPRAKTOR.COM ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  1.0% 0.7% 0.8% 1.0% 0.9%  
Credit score (0-100)  88 93 92 86 87  
Credit rating  A AA AA A A  
Credit limit (kDKK)  219.9 411.5 382.9 191.7 277.9  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  7,296 7,966 7,483 7,405 7,390  
EBITDA  1,446 1,178 850 335 492  
EBIT  1,296 1,101 674 118 287  
Pre-tax profit (PTP)  1,319.5 1,154.7 736.9 172.1 346.9  
Net earnings  1,029.1 900.7 574.8 134.3 270.4  
Pre-tax profit without non-rec. items  1,319 1,155 737 172 347  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  510 433 1,012 795 590  
Shareholders equity total  1,447 2,342 2,416 1,967 2,237  
Interest-bearing liabilities  96.5 0.0 0.2 293 0.0  
Balance sheet total (assets)  2,867 3,822 3,390 2,963 2,898  
Net Debt  -699 -349 -200 -115 -399  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  7,296 7,966 7,483 7,405 7,390  
Gross profit growth  2.8% 9.2% -6.1% -1.0% -0.2%  
Employees  12 12 11 11 12  
Employee growth %  0.0% 0.0% -8.3% 0.0% 9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,867 3,822 3,390 2,963 2,898  
Balance sheet change%  92.6% 33.3% -11.3% -12.6% -2.2%  
Added value  1,446.1 1,177.7 849.7 294.0 491.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  31 -154 403 -434 -409  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  17.8% 13.8% 9.0% 1.6% 3.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  61.7% 35.1% 21.0% 6.5% 12.5%  
ROI %  118.0% 59.5% 31.3% 8.7% 16.1%  
ROE %  102.1% 47.5% 24.2% 6.1% 12.9%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  50.5% 61.3% 71.3% 66.4% 77.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -48.3% -29.6% -23.5% -34.4% -81.1%  
Gearing %  6.7% 0.0% 0.0% 14.9% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  18.0% 38.0% 26,690.2% 24.4% 13.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.0 2.8 3.0 2.3 4.1  
Current Ratio  2.0 2.8 3.0 2.3 4.1  
Cash and cash equivalent  795.0 349.1 199.9 408.0 398.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,153.7 2,138.2 1,541.6 1,175.9 1,669.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  121 98 77 27 41  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  121 98 77 30 41  
EBIT / employee  108 92 61 11 24  
Net earnings / employee  86 75 52 12 23